Bibliografia Barker, P. M., Markiewicz, M., Parker, K. A., Walters, D. V. and Strang, L. B., 1990. Synergistic action of triiodothyronine and hydrocortisone on epinephrineinduced reabsorption of f<strong>eta</strong>l lung liquid. Pediatr Res. 27, 588-591. Barnes, P. J., 1991. Neuropeptides and asthma. Am Rev Respir Dis. 143, S28-32. Bartzokis, G., Beckson, M., Lu, P. H., Nuechterlein, K. H., Edwards, N. and Mintz, J., 2001. Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry. 58, 461-465. Bauer, K., 1987. Adenohypophyseal degradation of thyrotropin releasing hormone regulated by thyroid hormones. Nature. 330, 375-377. Bauer, K., Nowak, P. and Kleinkauf, H., 1981. Specificity of a serum peptidase hydrolyzing thyroliberin at pyroglutamyl-histidine bone. Eur J Biochem. 118, 173-176. Bayer, S. A., 1983. 3H-thymidine-radiographic studies of neurogenesis in the rat olfactory bulb. Exp Brain Res. 50, 329-340. Bayliss, D. A., Viana, F., Kanter, R. K., Szymeczek-Seay, C. L., Berger, A. J. and Millhorn, D. E., 1994. Early postnatal development of thyrotropin-releasing hormone (TRH) expression, TRH receptor binding, and TRH responses in neurons of rat brainstem. J Neurosci. 14, 821-833. Beal, M. F., Walker, L. C., Swartz, K. J., Casanova, M. F. and Price, D. L., 1988. Developmental changes of neuropeptides and amino acids in baboon cortex. Brain Res Dev Brain Res. 44, 156-159. Beaudet, A., Nouel, D., Stroh, T., Vandenbulcke, F., Dal-Farra, C. and Vincent, J. P., 1998. Fluorescent ligands for studying neuropeptide receptors by confocal microscopy. Braz J Med Biol Res. 31, 1479-1489. Beaulieu, C. and Colonnier, M., 1988. Richness of environment affects the number of contacts formed by boutons containing flat vesicles but does not alter the number of these boutons per neuron. J Comp Neurol. 274, 347-356. Beck, K. D., Powell-Braxton, L., Widmer, H. R., Valverde, J. and Hefti, F., 1995. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron. 14, 717-730. Bellemere, G., Morain, P., Vaudry, H. and Jegou, S., 2003. Effect of S 17092, a novel prolyl endopeptidase inhibitor, on substance P and alpha-melanocytestimulating hormone breakdown in the rat brain. J Neurochem. 84, 919-929. Bellemere, G., Vaudry, H., Mounien, L., Boutelet, I. and Jegou, S., 2004. Localization of the mRNA encoding prolyl endopeptidase in the rat brain and pituitary. J Comp Neurol. 471, 128-143. Bennett, G. W., Ballard, T. M., Watson, C. D. and Fone, K. C., 1997. Effect of neuropeptides on cognitive function. Exp Gerontol. 32, 451-469. Bennett, G. W., Edwards, R. M., Lighton, C. and Marsden, C. A., 1987. Thyrotrophin releasing hormone--5-hydroxytryptamine interactions in the brain studied using chronic immunization and chemical lesioning techniques. J Recept Res. 7, 555- 579. Bergstrom, L., Sakurada, T. and Terenius, L., 1984. Substance P levels in various regions of the rat central nervous system after acute and chronic morphine treatment. Life Sci. 35, 2375-2382. Bibliografia 219
Bibliografia Berl, S. and Clarke, D. D., 1972. Effects of LI + on the m<strong>eta</strong>bolism in brain of glutamate, glutamine, aspartate and GABA from (1- 14 C)ac<strong>eta</strong>te in vitro. Brain Res. 36, 203-213. Besse, S., Delcayre, C., Chevalier, B., Hardouin, S., Heymes, C., Bourgeois, F., Moalic, J. M. and Swynghedauw, B., 1994. Is the senescent heart overloaded and already failing? Cardiovasc Drugs Ther. 8, 581-587. Bhandrau, L. and Emerson, C. H., 1980. Evidence for the presence of the putative TRH m<strong>eta</strong>bolite, deamido-TRH, in human urine. J Clin Endocrinol M<strong>eta</strong>b. 51, 410-412. Bhargava, H. N., Das, S. and Bansinath, M., 1987. Proliferation of thyrotropin releasing hormone receptors in specific brain regions during the development of hypertension in spontaneously hypertensive rats. Peptides. 8, 231-235. Bhargava, H. N., Das, S., Bansinath, M. and Prasad, R., 1989. The binding of 3H-(3- MeHis2) thyrotropin releasing hormone to brain and pituitary membranes of morphine tolerant-dependent and abstinent rats. Pharmacol Biochem Behav. 34, 7-12. Bhargava, H. N. and Gulati, A., 1988. Binding of 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar- Kyoto normotensive rats. Pharmacology. 37, 349-355. Bidaud, I., Galas, L., Bulant, M., Jenks, B. G., Ouwens, D. T., Jegou, S., Ladram, A., Roubos, E. W., Tonon, M. C., Nicolas, P. and Vaudry, H., 2004. Distribution of the mRNAs encoding the thyrotropin-releasing hormone (TRH) precursor and three TRH receptors in the brain and pituitary of Xenopus laevis: effect of background color adaptation on TRH and TRH receptor gene expression. J Comp Neurol. 477, 11-28. Bilek, R., 2000. TRH-like peptides in prostate gland and other tissues. Physiol Res. 49 Suppl 1, S19-26. Blanchard, L. and Barden, N., 1986. Ontogeny of receptors for thyrotropin-releasing hormone in the rat brain. Brain Res. 389, 85-88. Blazquez, E., Perez Castillo, A. and de Diego, J. G., 1987. Characterization of glucagon receptors in liver membranes and isolated hepatocytes during rat ontogenic development. Mol Cell Endocrinol. 49, 149-157. Blebea, J., Mazo, J. E., Kihara, T. K., Vu, J. H., McLaughlin, P. J., Atnip, R. G. and Zagon, I. S., 2000. Opioid growth factor modulates angiogenesis. J Vasc Surg. 32, 364-373. Boler, J., Enzmann, F., Folkers, K., Bowers, C. Y. and Schally, A. V., 1969. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun. 37, 705-710. Borlongan, C. V., Stahl, C. E., Redei, E. and Wang, Y., 1999. Prepro-thyrotropinreleasing hormone 178-199 exerts partial protection against cerebral ischemia in adult rats. Neuroreport. 10, 3501-3505. Boschi, G., Launay, N. and Rips, R., 1980. Induction of wet-dog shakes by intracerebral 'acid' TRH in rats. Neurosci Lett. 16, 209-212. Bowers, C. R., Redding, T. W. and Schally, A. V., 1965. Effect of thyrotropin releasing factor (TRF) of ovine, bovine, porcine and human origin on thyrotropin release in vitro and in vivo. Endocrinology. 77, 609-616. 220 Bibliografia
- Page 1 and 2:
Jakintza-arloa: Medikuntza Prolil e
- Page 3 and 4:
UNIVERSIDAD DEL PAIS VASCO Eman ta
- Page 5 and 6:
Doktore-tesia Naiara Agirregoitia M
- Page 7 and 8:
Esker onak Lan hau hasi nuenetik mo
- Page 9:
David Artola Blancoren Oroimenez Es
- Page 12 and 13:
Aurkibidea SARRERA 1.NEUROPEPTIDOAK
- Page 14 and 15:
Aurkibidea 7.4. BIRIKAK 65 7.5. GIL
- Page 16:
Aurkibidea 2.4.PIROGLUTAMIL PEPTIDA
- Page 19 and 20:
Sarrera 2 Sarrera
- Page 21 and 22:
Neuropeptidoak dira: 4 Hurrengo tau
- Page 23 and 24:
Neuropeptidoak 6 1.2.4. Askapena Ne
- Page 26 and 27:
Tirotropinaren Hormona Askatzailea
- Page 28 and 29:
Tirotropinaren Hormona Askatzailea
- Page 30 and 31:
Tirotropinaren Hormona Askatzailea
- Page 32 and 33:
Tirotropinaren Hormona Askatzailea
- Page 34:
Tirotropinaren Hormona Askatzailea
- Page 37 and 38:
Prolil endopeptidasa burututako leh
- Page 39 and 40:
Prolil endopeptidasa 22 3.3. PROLIL
- Page 41 and 42:
Prolil endopeptidasa 24 3.5. GARRAN
- Page 43 and 44:
Piroglutamil peptidasa I Mutagenesi
- Page 45 and 46:
Piroglutamil peptidasa I Katuaren g
- Page 48 and 49:
5. GARUN GARAPENA 5.1. SARRERA 5.1.
- Page 50 and 51:
Garun garapena Rhombentzefaloaren k
- Page 52 and 53:
Garun garapena mekanismoa hurrengoe
- Page 54 and 55:
Garun garapena Oinarrizko morfologi
- Page 56 and 57:
Garun garapena egunetan, baina 40.
- Page 58 and 59:
Garun garapena badaude, eta entzima
- Page 60 and 61:
Garun garapena neuronen genesia (Fr
- Page 62 and 63:
Garun garapena hipotiroideoaren adi
- Page 64 and 65:
Garun garapena azpiko zati bat. Bi
- Page 66 and 67:
Garun garapena lank., 1984; Gayo et
- Page 68 and 69:
Organo periferikoen garapena 6.ORGA
- Page 70 and 71:
Organo periferikoen garapena Peptid
- Page 72 and 73:
Organo periferikoen garapena eta la
- Page 74 and 75:
Organo periferikoen garapena Birike
- Page 76:
Organo periferikoen garapena ondore
- Page 79 and 80:
Zahartzapena Entzefalinak eta TRH-a
- Page 81 and 82:
Zahartzapena Bradikininaren hartzai
- Page 83 and 84:
Zahartzapena igoerarekin bat dator.
- Page 86 and 87:
HELBURUA
- Page 88 and 89:
HELBURUA Helburua Organismoaren haz
- Page 90 and 91:
Helburua Peptidasa solugarrien egin
- Page 92 and 93:
MATERIALAK ETA METODOAK
- Page 94 and 95:
MATERIALAK ETA METODOAK Materialak
- Page 96 and 97:
3. PRODUKTU KIMIKOAK o Azetato sodi
- Page 98 and 99:
Materialak 4.2.ENTSEIU ENTZIMATIKOE
- Page 100 and 101:
B. METODOAK 1. ANIMALIEN PERFUSIO E
- Page 102 and 103:
1. IRUDIA: Animaliaren perfusioa. M
- Page 104 and 105:
3. IRUDIA: Garunaren lehenengo ebak
- Page 106 and 107:
2. LAGINEN PRESTAKUNTZA Metodoak Au
- Page 108 and 109:
Metodoak 3.AKTIBITATE ENTZIMATIKOAR
- Page 110 and 111:
Teknika Metodoak Substratu soluzioa
- Page 112 and 113:
Metodoak Materialak eta Metodoak 95
- Page 114 and 115:
EMAITZAK Prolil endopeptidasa solug
- Page 116:
UP/mg proteina 3000 2000 1000 0 Pro
- Page 119 and 120:
Mintzari loturiko prolil endopeptid
- Page 122 and 123:
1.2. PIROGLUTAMIL PEPTIDASA I 1.2.1
- Page 124:
UP/mg proteina 5000 4000 3000 2000
- Page 127 and 128:
Mintzari loturiko piroglutamil pept
- Page 129 and 130:
Prolil endopeptidasa garapenean 112
- Page 131 and 132:
Prolil endopeptidasa garapenean ham
- Page 133 and 134:
Prolil endopeptidasa garapenean PRO
- Page 135 and 136:
Prolil endopeptidasa garapenean Kor
- Page 137 and 138:
Prolil endopeptidasa solugarria gar
- Page 139 and 140:
Prolil endopeptidasa solugarria gar
- Page 141 and 142:
Prolil endopeptidasa solugarria gar
- Page 143 and 144:
Mintzari loturiko prolil endopeptid
- Page 146 and 147:
Mintzari loturiko prolil endopeptid
- Page 148 and 149:
Mintzari loturiko prolil endopeptid
- Page 150 and 151:
Mintzari loturiko prolil endopeptid
- Page 152 and 153:
UP/mg proteina 3000 2000 1000 0 Min
- Page 154 and 155:
UP/mg proteina 500 400 300 200 100
- Page 156 and 157:
UP/mg proteina 300 200 100 0 Mintza
- Page 158 and 159:
Piroglutamil peptidasa I solugarria
- Page 160 and 161:
Piroglutamil peptidasa I solugarria
- Page 162 and 163:
Piroglutamil peptidasa I solugarria
- Page 164 and 165:
Piroglutamil peptidasa I solugarria
- Page 166 and 167:
Piroglutamil peptidasa I solugarria
- Page 168 and 169:
Piroglutamil peptidasa I solugarria
- Page 170 and 171:
Mintzari loturiko piroglutamil pept
- Page 172 and 173:
Mintzari loturiko piroglutamil pept
- Page 174 and 175:
UP/mg proteina 600 400 200 0 Mintza
- Page 176 and 177:
UP/mg proteina 400 300 200 100 0 Mi
- Page 178 and 179:
UP/mg proteina 400 300 200 100 0 Mi
- Page 180 and 181:
UP/mg proteina 200 150 100 50 0 Min
- Page 182 and 183: UP/mg proteina 150 100 50 0 Mintzar
- Page 184 and 185: Prolil endopeptidasa zahartzapenean
- Page 186 and 187: Prolil endopeptidasa zahartzapenean
- Page 188 and 189: Prolil endopeptidasa zahartzapenean
- Page 190 and 191: Prolil endopeptidasa zahartzapenean
- Page 192 and 193: Prolil endopeptidasa zahartzapenean
- Page 194 and 195: Piroglutamil peptidasa I solugarria
- Page 196 and 197: UP/ mg proteina 400 300 200 100 0 P
- Page 198: UP/ mg proteina 5000 4000 3000 2000
- Page 201 and 202: Piroglutamil peptidasa I solugarria
- Page 203 and 204: Piroglutamil peptidasa I solugarria
- Page 205 and 206: EZTABAIDA
- Page 207 and 208: EZTABAIDA 1. PROLIL ENDOPEPTIDASA P
- Page 209 and 210: Prolil endopeptidasa Jaio berrian e
- Page 211 and 212: Prolil endopeptidasa peptido hauek
- Page 213: Prolil endopeptidasa 1.4. PROLIL EN
- Page 216 and 217: Piroglutamil peptidasa I Lehen aipa
- Page 218 and 219: Piroglutamil peptidasa I TRH-aren e
- Page 221 and 222: Emaitzen Analisi orokorra 3. EMAITZ
- Page 223 and 224: ONDORIOAK
- Page 225 and 226: ONDORIOAK Ondorioak 1. Prolil endop
- Page 228: BIBLIOGRAFIA
- Page 231: Bibliografia Aoyagi, T., Hatsu, M.,
- Page 235 and 236: Bibliografia Carr, F. E., Need, L.
- Page 237 and 238: Bibliografia de Gandarias, J. M., C
- Page 239 and 240: Bibliografia el-Dahr, S. S., 1997.
- Page 241 and 242: Bibliografia Gil, J., 1997. Ontogen
- Page 243 and 244: Bibliografia importance of cardiac
- Page 245 and 246: Bibliografia converting enzyme inhi
- Page 247 and 248: Bibliografia Lee, H. J., Sagawa, K.
- Page 249 and 250: Bibliografia Manaker, S., Eichen, A
- Page 251 and 252: Bibliografia hormone (TRH) in the p
- Page 253 and 254: Bibliografia Otto, C., Zuschratter,
- Page 255 and 256: Bibliografia Re, R. N., 2003a. Impl
- Page 257 and 258: Bibliografia Sidman, R. L., 1961. H
- Page 259 and 260: Bibliografia ten Have-Opbroek, A. A
- Page 261 and 262: Bibliografia Weil-Malherbe, H., 197
- Page 263: Bibliografia Zagon, I. S., Verderam